What Is Rheumatoid Arthritis? | NEJM
In this Double Take video from the New England Journal of Medicine, Drs. Schubach, Gravallese, and Firestein review the ...
NEJM Group
Dr. Glaucomflecken Explains: Antibiotic Treatment Duration for Bloodstream Infections (BALANCE)
Bloodstream infections are common and can be lethal, with more than 600000 cases and an estimated 90000 related deaths ...
NEJM Group
Getting Better: 200 Years of Medicine | NEJM
Getting Better is a short documentary that explores three remarkable stories of medical progress: Cancer, HIV/AIDS, Surgery.
NEJM Group
A Video Introduction to the New NEJM.org
This brief video introduces the redesigned NEJM.org with commentary from NEJM editors, including Jeffrey M. Drazen, M.D., ...
NEJM Group
NEJM This Week — February 12, 2026
This week includes studies on promising new therapies for IgA nephropathy, evolving antithrombotic strategies after coronary ...
NEJM Group
Medical Mystery Solved – A Treacherous Course | NEJM
This Double Take video from the New England Journal of Medicine presents the case of a man with acute onset of nausea, ...
NEJM Group
Medical Mystery Solved — The Devil Is in the Details | NEJM
This Double Take video from the New England Journal of Medicine describes a woman who presents with night sweats and ...
NEJM Group
Depression (Episode 2 of 4) — Treatment Options and Managing Depression in Primary Care | NEJM
In this second episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine, Drs.
NEJM Group
Medical Mystery Solved — Hunting for a Diagnosis | NEJM
This short video from the _New England Journal of Medicine_ highlights the effects of climate change on health through an ...
NEJM Group
Topical Antisepsis | NEJM
This is the first video in my partnership with @NEJMgroup in which I summarize the latest research using my unique set of skills ...
Dr. Glaucomflecken
Measles | NEJM
In this Double Take video from the New England Journal of Medicine, Drs. Pearl and Baden outline the presentation and ...
NEJM Group
NEJM This Week — January 29, 2026
This week, we explore new therapies to reduce pancreatitis risk in severe hypertriglyceridemia, advances in breast cancer ...
NEJM Group
Medical Mystery Solved — A Burning Question | NEJM
This Double Take video from the New England Journal of Medicine describes the case of a 35-year-old man presenting with 4 ...
NEJM Group
Medical Mystery Solved — Hard to Swallow | NEJM
This short Double Take video from the _New England Journal of Medicine_ emphasizes the importance of remaining vigilant in ...
NEJM Group
Weight and Health – Pathophysiology (Chapter 1 of 3) | NEJM
This video delves into the contributions of weight-regulating pathways, genetics, and the current societal environment that ...
NEJM Group
Medical Mystery Solved – A Deficient Diagnosis | NEJM
This Double Take video from the New England Journal of Medicine presents the case of a toddler with a limp. Based on a Clinical ...
NEJM Group
Intensive Blood-Pressure Control in Type 2 Diabetes | NEJM
Whether intensive systolic blood-pressure control or standard control is better for cardiovascular risk reduction in patients with ...
NEJM Group
Atrial Fibrillation and Catheter Ablation | NEJM
In this instructional video, Drs. Jane Leopold, Elliott Antman, William Sauer, and Paul Zei provide an overview of the classification ...
NEJM Group
When Weight Impacts Health | NEJM
In this short video for patients and families from the _New England Journal of Medicine,_ experts discuss the current ...
NEJM Group
NEJM This Week — April 16, 2026
This week, we present new research on stroke prevention, Kawasaki disease, ICU infection strategies, and immune ...
NEJM Group
The New England Journal of Medicine.
El ensayo clínico Destiny Breast-03, liderado por el Dr. Javier Cortés, presidente de la Fundación Contigo, ha sido publicado en ...
Fundación Contigo
HFpEF Explained — Living with HFpEF | NEJM
In this final episode of a three-part Double Take miniseries on heart failure with preserved ejection fraction (HFpEF) from the New ...
NEJM Group
NEJM Dialogues -- Maternal and Fetal Medicine
NEJM Group
Type 2 Diabetes — Controlling the Epidemic (Episode 4 of 4) | NEJM
In this fourth episode of “Type 2 Diabetes — Controlling the Epidemic,” a four- part Double Take video miniseries from the New ...
NEJM Group
HFpEF Explained — Prevalence, New Advances, and How to Diagnose | NEJM
This first episode of a three-part Double Take video miniseries on heart failure with preserved ejection fraction (HFpEF) from the ...
NEJM Group
Medical Mystery Solved — A Swell Diagnosis | NEJM
This Double Take video from the New England Journal of Medicine describes a man with recurrent severe diffuse abdominal pain ...
NEJM Group
Hand Hygiene | NEJM
Health-care associated infections are a threat to patient safety and the most common adverse events resulting from a stay in the ...
NEJM Group
Medical Mystery Solved – A Diagnostic Sequence | NEJM
This Double Take video from the New England Journal of Medicine presents the case of a 42-year-old woman presenting with ...
NEJM Group
Dr. Ken Wu Shares His Experience as an NEJM Editorial Fellow | NEJM
Dr. Ken Wu, a pediatrician and NEJM editorial fellow from 2019 to 2020, reflects on his experience as an NEJM editorial fellow ...
NEJM Group
COVID-19 Vaccine Study in New England Journal of Medicine
The New England Journal of Medicine is one of the most prestigious peer-reviewed journals of medicine. Learn about a recent ...
MedWatch Today
Antithrombosis for Atrial Fibrillation and Coronary Artery Disease | NEJM
Data are needed from randomized trials on a long-term antithrombotic treatment strategy for patients with atrial fibrillation and ...
NEJM Group
Publication in New England Journal of Medecine introduced by Professor Faiez Zannad
Professor Faiez Zannad introduces his new publication in the New England Journal of Medecine.
INICRCT
New England Journal of Medicine's Editor-in-Chief goes in-depth on COVID-19 vaccine
(ABC 6 NEWS)--The New England Journal of Medicine's Editor-in-Chief, Dr. Eric Rubin, went in-depth on COVID-19 vaccines and ...
ABC 6 News - KAAL TV
Dr. Glaucomflecken on Deferring Arterial Catheterization in Critically Ill Patients with Shock
In patients with shock, whether noninvasive blood-pressure monitoring is an effective alternative to the recommended use of an ...
NEJM Group
Interview with Dr. Jan-Inge Henter on New England Journal of Medicine Article
Our public health intern Emma interviewed Dr. Jan-Inge Henter after he published a review article about Hemophagocytic ...
Histiocytosis Association
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources int...
Eberechi Nwogu-Onyemkpa is an assistant professor in the Division of Palliative Medicine at Washington University in St. Louis.
NEJM Group
Cardiovascular Risk Factors — Lifestyle Modifications | NEJM
This second episode of a two-part Double Take miniseries on cardiovascular risk factors from the New England Journal of ...
NEJM Group
NEJM Interview: Dr. Timothy Quill on balancing evidence-based medicine and patient-centered care.
Dr. Timothy Quill is a professor of medicine, psychiatry, and medical humanities and the director of the Center for Ethics, ...
NEJM Group
60-Second Journal Club: 30-Year Cardiovascular Outcomes in Women
Can high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels be used to ...
NEJM Group
NEJM This Week — May 28, 2026
This week, we present new research guiding treatment of pulmonary embolism, early progress in cardiac regeneration with ...
NEJM Group
The New England Journal of Medicine Stroke Trials: What Do They Really Mean?
Related video presentation to the CLINICAL NEUROSURGERY article titled "The New England Journal of Medicine Stroke Trials: ...
NEUROSURGERY Journal
NEJM Interview: Dr. Nora Volkow on stigma against people who use drugs and its effects on care de...
Dr. Nora Volkow is the director of the National Institute on Drug Abuse. Stephen Morrissey, the interviewer, is the Executive ...
NEJM Group
